Our blog

June | Life Science Market Roundup: Deals, Breakthroughs & Funding News
June | Life Science Market Roundup: Deals, Breakthroughs & Funding News
by Katie Davis
Posted in Life Science & Diagnostics
June 2025 delivered major developments across the life science industry - from headline-grabbing acquisitions and AI-driven drug discovery partnerships to multi-million-dollar funding rounds and product innovations in diagnostics, genomics, and precision medicine. In this comprehensive roundup, Invenia Group Consultant Katie Davis highlights the companies and technologies driving the sector forward.
Read more
May Biotech Insights: Key Discoveries 2025
May Biotech Insights: Key Discoveries 2025
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. From funding to collaborations, acquisitions, product and legal updates, in this blog we explore the latest funding updates throughout the month of May.
Read more
Biotech Funding Rounds and Key Findings | March
Biotech Funding Rounds and Key Findings | March
by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of March.
Read more
Biotech Funding Q4 2024
Biotech Funding Q4 2024
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout Q4 2024.
Read more
Biotech Funding Rounds and Key Findings | February
Biotech Funding Rounds and Key Findings | February
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of February.
Read more
Hiring Mistakes: Where Do They Usually Start?
Hiring Mistakes: Where Do They Usually Start?
by Jacqueline Columbine
Posted in Biopharma, HealthTech, Life Science & Diagnostics, MedTech & Devices
Hiring the right talent is crucial to success. As a recruitment company specializing in life science and medical executive search, we’ve seen first-hand how hiring mistakes can derail even the most promising companies. But where do these mistakes typically start?
Read more
January Biotech Insights: Key Discoveries 2025
January Biotech Insights: Key Discoveries 2025
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry, whether that be funding news, acquisitions, spin outs and expansions, legal updates, layoffs and restructuring, collaborations or general product updates. In this blog, we explore the latest updates throughout the month of January.
Read more
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Across the life sciences market, IPOs are more than just fundraising —they are indicators of investor confidence and market potential. After a slowdown in recent years, IPO activity is picking up pace again in 2025, particularly within biotech. In this blog, Katie Davis explores the latest trends.
Read more
Nail Your Next Job Interview
Nail Your Next Job Interview
by Jacqueline Columbine
Posted in Biopharma, HealthTech, Life Science & Diagnostics, MedTech & Devices
56% of full-time employees in the US want a new job in 2025, and 27% have already started searching. The beginning of a new year is a time for fresh opportunities and setting goals, but the interview process can often feel like the most daunting part of landing your dream job.
Read more